Valion Bio (VBIO) Return on Assets [ROA] (2022 - 2026)
Valion Bio (VBIO) reported Return on Assets [ROA] of -42.06% for Q2 2026, up 82.50 percentage points from -124.56% a year earlier.
Powered by 
Analysis
Valion Bio (VBIO) Return on Assets [ROA] (2022 - 2026) Analysis & Trends
For FY2025, Valion Bio posted Return on Assets [ROA] of -51.60%, up 90.42 percentage points from FY2024.
- Return on Assets [ROA] has a three-year change of +44.97 percentage points (FY2022 to FY2025).
- By year, Return on Assets [ROA] came in at -142.01% in FY2024 (+7.44 pp), -149.46% in FY2023 (-52.89 pp) and -96.56% in FY2022.
- Five-year quarterly Return on Assets [ROA] spans a low of -180.27% in Q1 2024 and a high of -41.65% in Q4 2025.
- Year over year, Return on Assets [ROA] gained in five of the last seven quarters, with an average year-over-year change of +41.37 percentage points.
- The high point for year-over-year Return on Assets [ROA] in five years was Q4 2025 (a gain of 102.52 percentage points); the low point was Q1 2023 (a drop of 102.95 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 10.47% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 28.37% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.14% |
| 10 | Valion Bio | 350,167.99 | -19.09 Mn | - | -42.06% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -42.06% |
| Dec 31, 2025 | -41.65% |
| Sep 30, 2025 | -115.64% |
| Jun 30, 2025 | -124.56% |
| Mar 31, 2025 | -136.54% |
| Dec 31, 2024 | -144.17% |
| Sep 30, 2024 | -157.07% |
| Jun 30, 2024 | -167.33% |
| Mar 31, 2024 | -180.27% |
| Dec 31, 2023 | -135.56% |
| Sep 30, 2023 | -142.33% |
| Jun 30, 2023 | -155.27% |
| Mar 31, 2023 | -153.73% |
| Dec 31, 2022 | -143.42% |
| Sep 30, 2022 | -105.39% |
| Jun 30, 2022 | -74.03% |
| Mar 31, 2022 | -50.78% |
API Access
Valion Bio Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=VBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "VBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=VBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();